1. Ferreri AJ, Marturano E. Primary CNS lymphoma. Best Pract Res Clin Haematol. 2012;25(1):119-130. doi:10.1016/j.beha.2011.12.001
2. Dogan A, Doğan NY, Erkurt MA, Ekinci Ö, Kuku İ, Kaya E. Clinical and pathological characteristics of patients with non-Hodgkin lymphoma cases in Eastern Turkey. Cukurova Med J. 2020;45(2):533-540. doi:10.17826/cumj.672199
3. Thieblemont C, Gomes Da Silva M, Leppä S, et al. Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Hemasphere. 2025;9(9):e70207. doi:10.1002/hem3.70207
4. Vinnicombe S, Reznek R. Extranodal manifestations of lymphoma. Imaging. 1999;11(4):240-268. doi:10.1259/img.11.4.110240
5. Mak KS, Lee LK, Mak RH, et al. Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys. 2011;80(3):824-831. doi:10.1016/j.ijrobp.2010.03.022
6. Liu S-Z, Zhou X, Song A, Huo Z, Wang Y-P, Liu Y. Primary spinal epidural non-Hodgkin’s lymphoma causing complete paralysis. QJM. 2018;111(11):813-814. doi:10.1093/qjmed/hcy151
7. Nakamizo T, Inoue H, Udaka F, et al. Magnetic resonance imaging of primary spinal intramedullary lymphoma. J Neuroimaging. 2002;12(2): 183-186. doi:10.1111/j.1552-6569.2002.tb00118.x
8. Ferreri A, Reni M, Pasini F, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology. 2002;58(10):1513-1520. doi:10.1212/wnl.58.10.1513
9. Shu Y, Wang A, Yi L, Xu X, Yang W. Primary spinal epidural diffuse large B-cell lymphoma with paraplegia as the first manifestation: a case report. Onco Targets Ther. 2019;12:6497-6501. doi:10.2147/OTT.S217703
10. Tilly H, Morschhauser F, Sehn LH, et al. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med. 2022;386(4):351-363. doi:10.1056/NEJMoa2115304
11. Yaman S, Bozan E, Başcı S. Diffuse large B-cell lymphoma. In: Rezaei N, editor. Comprehensive Hematology and Stem Cell Research (First Edition). Oxford: Elsevier; 2024.
12. Pinar IE, Ozkocaman V, Ersal T, et al. Comparison of International Prognostic Indices and validation study for patients with diffuse large B-cell lymphoma in the rituximab era. UHOD. 2023;33(2):57-65. doi:10.4999/uhod.236953
13. Tang Y, Yang X, Xiao J, et al. Clinical outcomes of treatment for spinal cord compression due to primary non-Hodgkin lymphoma. Spine J. 2013;13(6):641-650. doi:10.1016/j.spinee.2012.11.054
14. Peng X, Wan Y, Chen Y, et al. Primary non-Hodgkin’s lymphoma of the spine with neurologic compression treated by radiotherapy and chemotherapy alone or combined with surgical decompression. Oncol Rep. 2009;21(5):1269-1275. doi:10.3892/or_00000350
15. Perry JR, Deodhare SS, Bilbao JM, Murray D, Muller P. The significance of spinal cord compression as the initial manifestation of lymphoma. Neurosurgery. 1993;32(2):157-162. doi:10.1227/00006123-199302000-00001